For example, UBC9 can promote the SUMOylation of PR-Set7, a chromatin-modifying enzyme that specifically monomethylates lysine 20 of histone H4 (H4K20me1), to further decrease the expression of downstream genes mediated by PR-Set7, potentially in response to DNA damage in breast cancer [148]. This evidence concerns the gene UBE2I and breast carcinoma.